Product
SUMMA 2.2
PHARMACEUTICAL
byPrecision Digital Health, Inc
United States (US)
ABOUT THE PRODUCT
SUMMA 2.2 is a comprehensive real-time continuous glucose monitoring platform that provides end-to-end CGM data management. The platform features modular solutions designed to support various trial designs, from direct-to-patient studies to hybrid and traditional clinical trial formats.
Information is owner-confirmed
Last updated 4 months ago
Price range